Research Paper Volume 13, Issue 8 pp 11988—12006

High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia

High expression of COMMD7 was associated with poor OS in AML patients. (A) Kaplan-Meier curves in all AML patients. (B) Kaplan-Meier curves in AML patients with BM blasts > 20%. (C) Kaplan-Meier curves in AML patients with PB blasts ≤ 70%. (D) Kaplan-Meier curves in AML patients with age ≥ 60. (E–L) Kaplan-Meier curves in subgroups with FLT3 mutation-negative, IDH1 R132 mutation-positive, IDH1 R140 mutation-positive, R172 mutation-positive, NPM1 mutation-positive, RAS mutation-positive, RUX1 mutation-negative, and DNMT3A mutation-negative in AML patients.

Figure 8. High expression of COMMD7 was associated with poor OS in AML patients. (A) Kaplan-Meier curves in all AML patients. (B) Kaplan-Meier curves in AML patients with BM blasts > 20%. (C) Kaplan-Meier curves in AML patients with PB blasts ≤ 70%. (D) Kaplan-Meier curves in AML patients with age ≥ 60. (EL) Kaplan-Meier curves in subgroups with FLT3 mutation-negative, IDH1 R132 mutation-positive, IDH1 R140 mutation-positive, R172 mutation-positive, NPM1 mutation-positive, RAS mutation-positive, RUX1 mutation-negative, and DNMT3A mutation-negative in AML patients.